Psychiatry Tomorrow

Delve into the evolving legal landscape of MDMA-assisted psychotherapy. This episode features Kimberly Chew and Karen Luong, co-leaders of the Psychedelic and Emerging Therapies group at Husch Blackwell. In this enlightening conversation, they decode the legal steps required to offer MDMA treatment for PTSD, a topic of interest for 60% of our surveyed clinicians.  They discuss the certification re...

Join us in this captivating episode as we explore the transformative potential of psychedelics with our guest, Andrew Penn, a registered Psychiatric Mental Health Nurse Practitioner (NP) and expert in the therapeutic use of psychedelics. We delve into the concept of small psycholytic changes versus monumental breakthrough experiences and the need for further research in this area. Andrew emphasize...

Join us in this riveting podcast as Ben McCauley, the founder of Denovo Therapy, sheds light on the evolution of his Lubbock-based clinic from a single provider to a beacon of hope for the broader community. The episode explores Denovo's commitment to meeting patients where they are and their innovative use of ketamine-assisted therapy, particularly in a conservative community often wary of such t...

In Psychiatry Tomorrow, we'll delve into the challenges and opportunities that lie ahead. We'll explore the delicate balance between new evidence-generating practices and timeless therapeutic wisdom. Our podcast is not intended to be individual medical advice.  Rather, our goal is to create a space for critical and in-depth conversations about where the field has been, and make predictions on wher...

In this episode, we engage in a nuanced discussion with Dr. Awais Aftab, a leading figure in critical psychiatry, exploring key issues in the field. We distinguish critical psychiatry from "anti-psychiatry," explore the influence of cultural movements on mental health discourse, and discuss the role of service users in advocating for better care. Dr. Aftab shares insights on the role and challenge...

The "placebo effect" gets a bad rap. The human mind is a powerful thing, capable of incredible feats of healing and transformation. Nowhere is this more evident than in the world of psychedelic research. Dr. Boris Heifets has spent years studying the neurobiological underpinnings of these compounds, but he knows that their true power lies in something much deeper.   In this interview, Dr. Boris He...

In this enlightening episode, host Carlene MacMillan, M.D., and guest Brittainy Wagner, LPC, delve into the potential of Esketamine (SPRAVATO®) as a breakthrough solution for treatment-resistant depression and acute suicidality. They explore how to successfully incorporate this novel treatment into your psychiatric practice, despite challenges like navigating the REMS program and understanding com...